Ezetimibe for the Treatment of Nonalcoholic Steatohepatitis: Assessment by Novel Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Randomized Trial (MOZART Trial)

Ezetimibe inhibits intestinal cholesterol absorption and lowers low-density lipoprotein cholesterol. Uncontrolled studies have suggested that it reduces liver fat as estimated by ultrasound in nonalcoholic steatohepatitis (NASH). Therefore, we aimed to examine the efficacy of ezetimibe versus placeb...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hepatology
Autori principali: Loomba, Rohit, Sirlin, Claude B, Ang, Brandon, Bettencourt, Ricki, Jain, Rashmi, Salotti, Joanie, Soaft, Linda, Hooker, Jonathan, Kono, Yuko, Bhatt, Archana, Hernandez, Laura, Nguyen, Phirum, Noureddin, Mazen, Haufe, William, Hooker, Catherine, Yin, Meng, Ehman, Richard, Lin, Grace Y, Valasek, Mark A, Brenner, David A, Richards, Lisa
Natura: Artigo
Lingua:Inglês
Pubblicazione: BlackWell Publishing Ltd 2015
Soggetti:
Steatohepatitis/Metabolic Liver Disease
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4407930/
https://ncbi.nlm.nih.gov/pubmed/25482832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27647
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi